Regiane Morillas Oliveira

Author

Universidade Federal de Goiás

Also Known As

Regiane M Oliveira, Regiane M. Oliveira, Regiane Morillas Oliveira, Regiane Morillas de Oliveira

Publications

401

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Goiás Infectious Disease Research Institute Instituto de Dermatologia Dona Libania Universidade Federal Fluminense Fundação de Medicina Tropical

About

Regiane Morillas Oliveira is an author at Universidade Federal de Goiás specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	134
2	Immunology	5	5	134
3	Microbiology	2	2	67
4	Pathology	2	2	65
5	Engineering	1	1	38

Regiane Morillas Oliveira

Publications

401

Citations

H-Index

Page 1

	Year	Citations
Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development Lucas Henrique Ferreira Sampaio, Mariane MA Stefani, Regiane Morillas Oliveira, BMC Infectious Diseases	2011	94
Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology Ludimila Paula Vaz Cardoso, Ronaldo Ferreira Dias, Aline Araújo Freitas, BMC Infectious Diseases	2013	85
Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR) Emerith Mayra Hungria, Samira Bührer-Sékula, Regiane Morillas Oliveira, PLoS neglected tropical diseases	2017	41
Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil Emerith Mayra Hungria, Regiane Morillas Oliveira, Ana Lúcia Osório Maroclo de Souza, Memórias do Instituto Oswaldo Cruz EngineeringImmunologyPathologySerologic TestingDifferent Leprosy-endemic Regions	2012	38
Protection against Mycobacterium leprae Infection by the ID83/GLA-SE and ID93/GLA-SE Vaccines Developed for Tuberculosis Malcolm S. Duthie, Rhea N. Coler, John D. Laurance, Infection and Immunity ImmunodeficienciesTuberculosis PreventionImmunologyImmunodominanceMycobacterium Leprae Infection	2014	29
Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions Danielle de Freitas Mizoguti, Emerith Mayra Hungria, Aline Araújo Freitas, Memórias do Instituto Oswaldo Cruz ImmunodeficienciesImmunologyDiagnosisPathologyImmunotherapy	2015	27
Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil Emerith Mayra Hungria, Regiane Morillas Oliveira, Gerson Oliveira Penna, Infectious Diseases of Poverty	2016	24
Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT Emerith Mayra Hungria, Samira Bührer-Sékula, Regiane Morillas Oliveira, Frontiers in Immunology	2018	23
Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy Aline Araújo Freitas, Regiane Morillas Oliveira, Emerith Mayra Hungria, Diagnostic Microbiology and Infectious Disease Autoimmune DiseaseImmunodeficienciesMultidrug TherapyImmunologyAntigen-specific Immune Responses	2015	22
Development and pre-clinical assessment of a 73kD chimeric fusion protein as a defined sub-unit vaccine for leprosy Malcolm S. Duthie, Lucas Henrique Ferreira Sampaio, Regiane Morillas Oliveira, Vaccine VaccinationVaccine DevelopmentMedicineImmunodeficienciesPathogenesis	2012	18

Page 1